Tower Research Capital (TRC)’s Pasithea Therapeutics KTTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$910 Sell
2025
Q1
$4.25K Buy
2024
Q4
$5.94K Buy
2024
Q3
$3.26K Sell
2024
Q2
$9.14K Buy
2024
Q1
$9.75K Buy
2023
Q4
$4.59K Sell
2023
Q3
$6K Buy
2023
Q2
$6.12K Sell
2023
Q1
$5K Sell
2022
Q4
$10K Buy
2022
Q3
$7K Buy
2022
Q2
$2K Buy
2022
Q1
Sell
2021
Q4
$52K Buy
2021
Q3
$6K Buy